CONSOLI, MARIA LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 273
EU - Europa 120
AS - Asia 96
AF - Africa 47
SA - Sud America 25
Totale 561
Nazione #
US - Stati Uniti d'America 269
SG - Singapore 50
IT - Italia 30
IE - Irlanda 29
CI - Costa d'Avorio 28
BR - Brasile 23
CN - Cina 23
DE - Germania 21
SN - Senegal 14
VN - Vietnam 13
UA - Ucraina 9
RU - Federazione Russa 7
CA - Canada 4
GB - Regno Unito 4
IN - India 4
BE - Belgio 3
CH - Svizzera 3
MA - Marocco 3
SE - Svezia 3
AR - Argentina 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
GR - Grecia 2
LB - Libano 2
LU - Lussemburgo 2
TR - Turchia 2
UZ - Uzbekistan 2
EG - Egitto 1
NO - Norvegia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 561
Città #
Chandler 62
Santa Clara 58
Singapore 40
Chicago 30
Dublin 29
Abidjan 28
Civitanova Marche 16
Dakar 14
Jacksonville 10
Boardman 9
Munich 9
Andover 8
Cambridge 8
Lawrence 8
Dong Ket 7
Grafing 7
Ashburn 6
Hanoi 6
Des Moines 4
Florence 4
Los Angeles 4
Nanjing 4
Saint Petersburg 4
Brussels 3
Houston 3
Portland 3
São Paulo 3
Wilmington 3
Beijing 2
Belo Horizonte 2
Bengaluru 2
Bremen 2
Casablanca 2
Changsha 2
Council Bluffs 2
Newham 2
The Dalles 2
Toronto 2
Turku 2
Ahmetli 1
Aryanah 1
Bratislava 1
Brno 1
Cairo 1
Caldas Novas 1
Cascavel 1
Catania 1
Catende 1
Cianorte 1
Colombo 1
Curvelo 1
Cáceres 1
Fortaleza 1
Guarapuava 1
Hanover 1
Hebei 1
Istanbul 1
Itabira 1
Jiaxing 1
Joinville 1
João Monlevade 1
Laayoune 1
Luxembourg 1
Magé 1
Manchester 1
Melrose 1
Merlo 1
Montreal 1
Moscow 1
New York 1
Noida 1
Oslo 1
Ottawa 1
Passo Fundo 1
Paulo Afonso 1
Quintano 1
San Francisco 1
San Luis 1
San Mateo 1
Shenyang 1
Simões Filho 1
Tianjin 1
Torre A Mare 1
Três Lagoas 1
Valparaíso de Goiás 1
Xingtai 1
Totale 459
Nome #
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 90
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 80
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 78
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 78
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 71
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents 64
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 60
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients 53
Totale 574
Categoria #
all - tutte 2.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 6 6
2020/202136 1 1 2 3 9 0 2 0 8 0 3 7
2021/202259 2 16 0 0 11 1 8 1 4 0 1 15
2022/2023153 9 16 1 24 7 25 1 30 30 3 5 2
2023/202471 2 17 0 2 3 21 0 2 0 4 15 5
2024/2025219 3 46 13 29 42 31 19 7 8 13 8 0
Totale 574